Yingbin M. Wang

State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo.

An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo.

Journal: Science translational medicine

Published: January 14, 2026

Redox-Responsive Peptide Coacervates for Enhanced mRNA Delivery and Intracellular Release.

Redox-Responsive Peptide Coacervates for Enhanced mRNA Delivery and Intracellular Release.

Journal: ACS nano

Published: December 26, 2025

An engineered VSV-vectored rabies vaccine with an RABV-G-L71S mutation.

An engineered VSV-vectored rabies vaccine with an RABV-G-L71S mutation.

Journal: iScience

Published: March 01, 2025

VP8 Mosaic Nanoparticles Elicit Cross-Neutralizing Immune Responses and Provide Protection Against Heterotypic Rotavirus Challenge in Mice.

VP8 Mosaic Nanoparticles Elicit Cross-Neutralizing Immune Responses and Provide Protection Against Heterotypic Rotavirus Challenge in Mice.

Journal: ACS nano

Published: November 05, 2024

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus.

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus.

Journal: Journal of clinical microbiology

Published: December 01, 2023

Roots applicable, high sensitivity and specificity assay for the detection of Candidatus Liberibacter asiaticus in citrus roots and fruits.

Roots applicable, high sensitivity and specificity assay for the detection of Candidatus Liberibacter asiaticus in citrus roots and fruits.

Journal: Plant biotechnology (Tokyo, Japan)

Published: October 05, 2023

Micronanoparticled risedronate exhibits potent vaccine adjuvant effects.

Micronanoparticled risedronate exhibits potent vaccine adjuvant effects.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 14, 2023

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo.

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo.

Journal: Frontiers in pharmacology

Published: April 28, 2023

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.

Journal: Frontiers in immunology

Published: March 10, 2023

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels.

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels.

Journal: Journal of hepatology

Published: March 04, 2023

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice.

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice.

Journal: Frontiers in microbiology

Published: February 24, 2023

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.

Journal: Journal of virology

Published: February 23, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026